TGFB1 and Duchenne muscular dystrophy: These findings align with a previous study that reported that Ang‐(1‐7) treatment reduced the expression of collagen types I and III, as well as the inhibition of signalling pathways controlled by TGF‐β/Smad in animals with Duchenne muscular dystrophy [18].